Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Ruth

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
The American Journal of Psychiatry|October 3, 2002
PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic maniaLakshmi N Yatham, Peter F Liddle, Raymond W Lam, et al.
Synapse (New York, N.Y.)|April 24, 2003
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PETRaúl De La Fuente-Fernández, Sarah Furtado, Mark Guttman, et al.
Nuclear Medicine and Biology|January 10, 2012
An automated module for the separation and purification of cyclotron-produced 99mTcO4-Thomas J Morley, Maurice Dodd, Katherine Gagnon, et al.
Brain : a Journal of Neurology|August 27, 2004
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesiasRaúl de la Fuente-Fernández, Vesna Sossi, Zhigao Huang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 30, 2006
Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studiesKaveh M Koochesfahani, Raúl de la Fuente-Fernández, Vesna Sossi, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 2, 2010
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depressionLakshmi N Yatham, Peter F Liddle, Raymond W Lam, et al.
Scientific Reports|January 5, 2016
Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy StressWieslawa H Dragowska, Mihaela Ginj, Piotr Kozlowski, et al.
Synapse (New York, N.Y.)|October 24, 2009
Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor functionAndré R Troiano, Michael Schulzer, Raul de la Fuente-Fernandez, et al.
Nuclear Medicine and Biology|August 13, 2015
Production of Y-86 and other radiometals for research purposes using a solution target systemElisabeth Oehlke, Cornelia Hoehr, Xinchi Hou, et al.
Journal of the American Chemical Society|August 15, 2008
Toward [18F]-labeled aryltrifluoroborate radiotracers: in vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in miceRichard Ting, Curtis Harwig, Ulrich auf dem Keller, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
The American Journal of Psychiatry|October 3, 2002
PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic maniaLakshmi N Yatham, Peter F Liddle, Raymond W Lam, et al.
Synapse (New York, N.Y.)|April 24, 2003
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PETRaúl De La Fuente-Fernández, Sarah Furtado, Mark Guttman, et al.
Nuclear Medicine and Biology|January 10, 2012
An automated module for the separation and purification of cyclotron-produced 99mTcO4-Thomas J Morley, Maurice Dodd, Katherine Gagnon, et al.
Brain : a Journal of Neurology|August 27, 2004
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesiasRaúl de la Fuente-Fernández, Vesna Sossi, Zhigao Huang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 30, 2006
Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studiesKaveh M Koochesfahani, Raúl de la Fuente-Fernández, Vesna Sossi, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 2, 2010
Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depressionLakshmi N Yatham, Peter F Liddle, Raymond W Lam, et al.
Scientific Reports|January 5, 2016
Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy StressWieslawa H Dragowska, Mihaela Ginj, Piotr Kozlowski, et al.
Synapse (New York, N.Y.)|October 24, 2009
Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor functionAndré R Troiano, Michael Schulzer, Raul de la Fuente-Fernandez, et al.
Nuclear Medicine and Biology|August 13, 2015
Production of Y-86 and other radiometals for research purposes using a solution target systemElisabeth Oehlke, Cornelia Hoehr, Xinchi Hou, et al.
Journal of the American Chemical Society|August 15, 2008
Toward [18F]-labeled aryltrifluoroborate radiotracers: in vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in miceRichard Ting, Curtis Harwig, Ulrich auf dem Keller, et al.
Pageof 6